Report #2826516

Received Feb 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 0.2 yrs
State: PA
Recovered: Unknown
Vaccinated: Jan 20, 2025
Onset: Jan 20, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
FLU3	INFLUENZA (SEASONAL) (FLULAVAL)	GLAXOSMITHKLINE BIOLOGICALS	UNK	AE2J7	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

administration of Flulaval to a 2 month old baby; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (batch number AE2J7, expiry date 16-JUN-2025) for prophylaxis. On 20-JAN-2025, the patient received FluLaval 2024-2025 season. On 20-JAN-2025, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced inappropriate age at vaccine administration (Verbatim: administration of Flulaval to a 2 month old baby). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-JAN-2025 A nurse called to report the administration of Flulaval to a 2 month old patient which led inappropriate age at vaccine administration. The reporter consented to follow up.